Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2011-07-19
2011-07-19
Gussow, Anne M. (Department: 1643)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387300, C530S388100, C424S130100, C424S133100, C424S145100, C435S069600
Reexamination Certificate
active
07982017
ABSTRACT:
The present invention provides antibodies (such as chimeric and humanized antibodies) specifically bind to an epitope on CD43 and CEA expressed on nonhematopoietic cancer cells. In addition, the present invention also provides use of the antibodies described herein for diagnostic and therapeutic purposes.
REFERENCES:
patent: 4036945 (1977-07-01), Haber
patent: 4331647 (1982-05-01), Goldenberg
patent: 4676980 (1987-06-01), Segal et al.
patent: 4683195 (1987-07-01), Mullis et al.
patent: 4683202 (1987-07-01), Mullis
patent: 4754065 (1988-06-01), Levenson et al.
patent: 4777127 (1988-10-01), Suni et al.
patent: 4800159 (1989-01-01), Mullis et al.
patent: 4816567 (1989-03-01), Cabilly et al.
patent: 5047335 (1991-09-01), Paulson et al.
patent: 5219740 (1993-06-01), Miller et al.
patent: 5278299 (1994-01-01), Wong et al.
patent: 5314995 (1994-05-01), Fell, Jr. et al.
patent: 5422120 (1995-06-01), Kim
patent: 5500362 (1996-03-01), Robinson et al.
patent: 5510261 (1996-04-01), Goochee et al.
patent: 5530101 (1996-06-01), Queen et al.
patent: 5545806 (1996-08-01), Lonberg et al.
patent: 5545807 (1996-08-01), Surani et al.
patent: 5565332 (1996-10-01), Hoogenboom et al.
patent: 5569825 (1996-10-01), Lonberg et al.
patent: 5580717 (1996-12-01), Dower et al.
patent: 5580859 (1996-12-01), Felgner et al.
patent: 5585089 (1996-12-01), Queen et al.
patent: 5625126 (1997-04-01), Lonberg et al.
patent: 5633425 (1997-05-01), Lonberg et al.
patent: 5661016 (1997-08-01), Lonberg et al.
patent: 5677427 (1997-10-01), Goldenberg et al.
patent: 5693761 (1997-12-01), Queen et al.
patent: 5693762 (1997-12-01), Queen et al.
patent: 5733743 (1998-03-01), Johnson et al.
patent: 5750373 (1998-05-01), Garrard et al.
patent: 5772997 (1998-06-01), Hudziak et al.
patent: 5807715 (1998-09-01), Morrison et al.
patent: 5814482 (1998-09-01), Dubensky, Jr. et al.
patent: 5821337 (1998-10-01), Carter et al.
patent: 5866692 (1999-02-01), Shitara et al.
patent: 5997867 (1999-12-01), Waldmann et al.
patent: 6048703 (2000-04-01), Siman et al.
patent: 6120767 (2000-09-01), Robinson et al.
patent: 6180370 (2001-01-01), Queen et al.
patent: 6265150 (2001-07-01), Terstappen et al.
patent: 6291643 (2001-09-01), Zou et al.
patent: 6329508 (2001-12-01), Friden
patent: 6331415 (2001-12-01), Cabilly et al.
patent: 6376471 (2002-04-01), Lawrence, III et al.
patent: 6413942 (2002-07-01), Felgner et al.
patent: 6436908 (2002-08-01), Koch et al.
patent: 6548640 (2003-04-01), Winter
patent: 6652852 (2003-11-01), Robinson et al.
patent: 6808901 (2004-10-01), Neuberger et al.
patent: 7674605 (2010-03-01), Lin et al.
patent: 2003/0027763 (2003-02-01), Bennett et al.
patent: 2008/0171043 (2008-07-01), Lin et al.
patent: 2010/0124551 (2010-05-01), Lin et al.
patent: 37570/93 (1993-10-01), None
patent: 0 345 242 (1989-12-01), None
patent: 0 345 242 (1989-12-01), None
patent: 0 528 767 (1993-02-01), None
patent: 0 396 387 (1993-12-01), None
patent: 0 524 968 (1995-07-01), None
patent: 1 782 838 (2007-05-01), None
patent: 2200651 (1988-08-01), None
patent: WO-87/04462 (1987-07-01), None
patent: WO-89/12624 (1989-12-01), None
patent: WO-89/12624 (1989-12-01), None
patent: WO-90/07936 (1990-07-01), None
patent: WO-90/11092 (1990-10-01), None
patent: WO-91/00360 (1991-01-01), None
patent: WO-91/00904 (1991-01-01), None
patent: WO-91/02805 (1991-03-01), None
patent: WO-91/02805 (1991-03-01), None
patent: WO-91/14438 (1991-10-01), None
patent: WO-91/14445 (1991-10-01), None
patent: WO-92/08495 (1992-05-01), None
patent: WO-92/20373 (1992-11-01), None
patent: WO-93/03769 (1993-03-01), None
patent: WO-93/06213 (1993-04-01), None
patent: WO-93/10218 (1993-05-01), None
patent: WO-93/11230 (1993-06-01), None
patent: WO-93/19191 (1993-09-01), None
patent: WO-93/25234 (1993-12-01), None
patent: WO-93/25698 (1993-12-01), None
patent: WO-94/03622 (1994-02-01), None
patent: WO-94/04690 (1994-03-01), None
patent: WO-94/12649 (1994-06-01), None
patent: WO-94/12649 (1994-06-01), None
patent: WO-94/23697 (1994-10-01), None
patent: WO-94/28938 (1994-12-01), None
patent: WO-95/00655 (1995-01-01), None
patent: WO-95/07994 (1995-03-01), None
patent: WO-95/07994 (1995-03-01), None
patent: WO-95/11984 (1995-05-01), None
patent: WO-95/11984 (1995-05-01), None
patent: WO-95/13796 (1995-05-01), None
patent: WO-95/30763 (1995-11-01), None
patent: WO-95/30763 (1995-11-01), None
patent: WO-96/17072 (1996-06-01), None
patent: WO-97/42338 (1997-11-01), None
patent: WO-99/58572 (1999-11-01), None
patent: WO-2006/001348 (2006-01-01), None
patent: WO-2007/146172 (2007-12-01), None
patent: WO-2007/146172 (2007-12-01), None
patent: WO-2007/146172 (2007-12-01), None
patent: WO-2009/079649 (2009-06-01), None
Skolnick and Fetrow. From genes to protein structure and function: novel applications of computational approaches in the genomic era. Trends in Biotechnology, 2000. vol. 18, pp. 34-39.
Burgess, Shaheen, Ravera, Jaye, Donohue, and Winkles. Possible dissociation of the heparin binding and mitogenic activities of heparin binding (acidic fibroblast) growth factor-1 from its receptor binding activities by site directed mutagenesis of a single lysine residue. Journal of Cell Biology, 1990. vol. 111, pp. 2129-2138.
Lazar, Watanabe, Dalton, and Sporn. Transforming growth factor alpha: mutation of aspartic acid 47 and leucine 48 results in different biological activities Molecular and Cellular Biology, 1988. vol. 8, pp. 1247-1252.
Holm, Jafari, and Sundstrom. Functional mapping and single chain construction of the anti-cytokeratin 8 monoclonal antibody TS1. Molecular Immunology, 2007. vol. 44, pp. 1075-1084.
Chen, Wiesmann, Fuh, Li, Christinger, Mc Kay, De Vos, and Lowman. Selection and analysis of an optimized anti-VEGF antibody: crystal structure of an affinity matured Fab in complex with antigen. Journal of Molecular Biology, 1999. vol. 293, pp. 865-881.
Al-Lazikani, B. et al. (Nov. 7, 1997). “Standard Conformations for the Canonical Structures of Immunoglobulins,”Journal of Molecular Biology273(4):927-948.
Baeckström, D. et al. (Nov. 15, 1991). “Purification and Characterization of a Membrane-Bound and a Secreted Mucin-Type Glycoprotein Carrying the Carcinoma-Associated Sialyl-leaEpitope on Distinct Core Proteins,”J. Biol. Chem. 266(32):21537-21547.
Baeckström, D. et al. (Jun. 9, 1995). “Expression of the Leukocyte-associated Sialoglycoprotein CD43 by a Colon Carcinoma Cell Line,”Journal of Biological Chemistry270(23):13688-13692.
Baeckström, D. et al. (Apr. 25, 1997). “Post-translation Fate of Mucin-like Leukocyte Sialoglycoprotein (CD43) Aberrantly Expressed in a Colon Carcinoma Cell Line,”Journal of Biological Chemistry272(17):11503-11509.
Ba{hacek over (z)}il, V. et al. (Feb. 15, 1996). “A Monoclonal Antibody Recognizing CD43 (leukosialin) Initiates Apoptosis of Human Hematopoietic Progenitor Cells But Not Stem Cells,”Blood87(4):1272-1281.
Belhocine, T. et al. (Feb. 2004). “The Imaging of Apoptosis with the Radiolabeled Annexin V: Optimal Timing for Clinical Feasibility,”Technology in Cancer Research and Treatment3(1):23-32.
Boerner, P. et al. (Jul. 1, 1991). “Production of Antigen-Specific Human Monoclonal Antibodies from In Vitro-primed Human Splenocytes,”Journal of Immunology147(1):86-95.
Boyd, P.N. et al. (1995). “The Effect of the Removal of Sialic Acid, Galactose and Total Carbohydrate on the Functional Activity of Campath-1 H,”Molecular Immunology32(17/18):1311-1318.
Brodeur, B.R. et al. (1987). “Mouse-Human Myeloma Partners for the Production of Heterohybridomas,” Chapter 4,In Monoclonal Antibody Production Techniques and Applications, Schook, L. ed., Marcel Dekker Inc.: New York, NY, 51-63.
Brown, T.J. et al. (1996). “Characterization of a CD43/Leukosialin-Mediated Pathway for Inducing Apoptosis in Human T-Lymphoblastoid Cells,”Journal of Biological Chemistry271(44):27686-27695.
Burton, D.R. (1985). “Review. Immunoglobulin G: Functional Sites,”Mol. Immunol. 22(3):161-206.
Cabilly, S. et al. (1984). &#x
Lin Leewen
Lin Shih-Yao
Tsai Yu-Ying
BioAlliance C.V.
Gussow Anne M.
Morrison & Foerster / LLP
LandOfFree
Antibodies recognizing a carbohydrate containing epitope on... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibodies recognizing a carbohydrate containing epitope on..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibodies recognizing a carbohydrate containing epitope on... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2671928